Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	9,922	9,639	9,359	10,626	11,850	13,349	14,405	16,963	19,484	23,115	20,533
COGS	-1,960	-1,966	2,631	3,038	3,574	4,123	5,046	5,070	5,039	6,066	6,738
Gross profit	—	—	6,728	7,588	8,277	9,226	9,359	11,892	14,445	17,050	13,795
	10,475	10,666	5,398	5,288	5,407	6,089	6,765	7,678	8,518	9,668	9,878
	1,407	939	1,330	2,300	2,870	3,137	2,594	4,215	5,926	7,382	3,917
OPM %	14.2%	9.7%	14.2%	21.6%	24.2%	23.5%	18%	24.9%	30.4%	31.9%	19.1%
Depreciation	—	—	774	781	789	835	814	923	976	1,039	1,207
Interest	64	57	63	57	48	47	38	17	22	110	148
	307	604	204	238	743	801	482	591	862	1,003	1,690
Profit before tax	1,580	1,545	697	1,701	2,776	3,056	2,224	3,866	5,791	7,236	4,251
Tax	226	160	130	423	-162	870	601	1,253	1,449	1,887	1,032
Tax %	14.3%	10.4%	18.7%	24.9%	-5.8%	28.5%	27%	32.4%	25%	26.1%	24.3%
	1,354	1,384	567	1,277	2,938	2,186	1,623	2,613	4,342	5,349	3,220
PAT margin %	13.7%	14.4%	6.1%	12%	24.8%	16.4%	11.3%	15.4%	22.3%	23.1%	15.7%
EPS (₹)	79.4	83	34.2	77	177.2	131.8	97.9	157.4	261	64.2	38.7
EPS adjusted (₹)	—	—	—	—	—	26.3	19.5	31.4	52.1	64.1	38.6
	25.2%	24.1%	58.5%	26%	14.1%	19%	30.7%	25.4%	15.3%	12.5%	20.7%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	83	83	83	83	83	84
Reserves	16,901	18,253	20,391	24,157	28,773	31,282
	1,181	2,171	51	710	3,386	5,419
	3,465	3,988	4,850	5,409	6,049	6,818
Total equity & liabilities	21,630	24,496	25,375	30,359	38,291	43,602
	5,844	6,151	7,207	7,589	8,232	10,730
CWIP	877	1,186	899	1,172	2,156	1,369
Investments	4,649	4,937	7,440	7,321	13,194	15,595
	10,259	12,222	9,829	14,278	14,709	15,908
Total assets	21,630	24,496	25,375	30,359	38,291	43,602

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Global Generics	18,202.7	4,371.6	0	0
Pharmaceutical Services and Active Ingredients	2,975	-88.3	0	0
Others	46.4

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	3,514	1,339	5,053	3,450	4,225	4,661
	-1,458	-2,038	-3,448	-3,430	-5,698	-5,785
	-794	506	-2,697	68	1,591	1,117
Net cash flow	1,262	-194	-1,092	88	118	-7
Free cash flow	2,657	27	4,053	2,089	1,886	2,611
CFO / Operating profit %	112%	51.6%	119.9%	58.2%	57.2%	119%